BrightHeart

BrightHeart is a medical technology company headquartered in Paris, France, that develops artificial intelligence software focused on improving the detection of fetal congenital heart defects. Its software uses artificial intelligence to analyze fetal echocardiograms and supports clinicians in prenatal identification of congenital heart defects. With access to a proprietary database of over 20,000 fetal ultrasound examinations, the technology leverages expertise in artificial intelligence and fetal echocardiography imaging to help caregivers improve the detection of complex fetal heart defects in utero during ultrasound screening. Early intervention can correct these defects or enhance the survival chances of affected children.